Professor Mahmoud Bukar Maina, a Nigerian neuroscientist, has warned that Africans could continue to consume medicines developed without adequate testing on African populations, leaving patients exposed to treatments whose effects may not be fully understood in the continent. Maina said the problem was not limited to dementia research, but extended to…